Avapritinib

Enquire Best Price to Buy Avapritinib in India

About API Sacituzumab Avapritinib:

Avapritinib is a kinase inhibitor developed to target specific KIT and PDGFRA mutations, including the difficult-to-treat PDGFRA D842V mutation. It serves as a targeted therapeutic option for patients with advanced systemic mastocytosis and gastrointestinal stromal tumors (GIST). It exhibits strong penetration into the central nervous system along with high selectivity, contributing to significant clinical activity and sustained responses. Its distinct mechanism of action makes it suitable for use in cancers driven by these mutations where treatment alternatives may be limited.